Cargando…

RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma

Background: Malignant glioma (MG) is an aggressive malignant brain tumor. Despite advances in multidisciplinary treatment, overall survival rates remain low. A trifluoroethyl amide derivative of 2-cyano-3-,12-dioxoolean-1,9-dien-28-oic acid (CDDO), CDDO–trifluoroethyl amide (CDDO–TFEA) is a nuclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Tai-Hsin, Lieu, Ann-Shung, Huang, Tzuu-Yuan, Kwan, Aij-Lie, Lin, Chih-Lung, Hsu, Yi-Chiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585078/
https://www.ncbi.nlm.nih.gov/pubmed/34768325
http://dx.doi.org/10.3390/jcm10214805
_version_ 1784597604409016320
author Tsai, Tai-Hsin
Lieu, Ann-Shung
Huang, Tzuu-Yuan
Kwan, Aij-Lie
Lin, Chih-Lung
Hsu, Yi-Chiang
author_facet Tsai, Tai-Hsin
Lieu, Ann-Shung
Huang, Tzuu-Yuan
Kwan, Aij-Lie
Lin, Chih-Lung
Hsu, Yi-Chiang
author_sort Tsai, Tai-Hsin
collection PubMed
description Background: Malignant glioma (MG) is an aggressive malignant brain tumor. Despite advances in multidisciplinary treatment, overall survival rates remain low. A trifluoroethyl amide derivative of 2-cyano-3-,12-dioxoolean-1,9-dien-28-oic acid (CDDO), CDDO–trifluoroethyl amide (CDDO–TFEA) is a nuclear erythroid 2-related factor 2/antioxidant response element pathway activator. RTA404 is used to inhibit proliferation and induce apoptosis in cancer cells. However, its effect on tumorigenesis in glioma is unclear. Methods: This in vitro study evaluated the effects of RTA404 on MG cells. We treated U87MG cell lines with RTA404 and performed assessments of apoptosis and cell cycle distributions. DNA content and apoptosis induction were subjected to flow cytometry analysis. The mitotic index was assessed based on MPM-2 expression. Protein expression was analyzed through Western blotting. Results: RTA404 significantly inhibited the cell viability and induced cell apoptosis on the U87MG cell line. The Annexin-FITC/PI assay revealed significant changes in the percentage of apoptotic cells. Treatment with RTA404 led to a significant reduction in the U87MG cells’ mitochondrial membrane potential. A significant rise in the percentage of caspase-3 activity was detected in the treated cells. In addition, these results suggest that cells pass the G2 checkpoint without cell cycle arrest by RTA404 treatment in the MPM-2 staining. An analysis of CHK1, CHK2, and p-CHK2 expression suggested that the DNA damage checkpoint system seems also to be activated by RTA404 treatment in established U87MG cells. Therefore, RTA404 may not only activate the DNA damage checkpoint system, it may also exert apoptosis in established U87MG cells. Conclusions: RTA404 inhibits the cell viability of gliomas and induces cancer cell apoptosis through intrinsic apoptotic pathway in Malignant glioma. In addition, the DNA damage checkpoint system seems also to be activated by RTA404. Taken together, RTA404 activated the DNA damage checkpoint system and induced apoptosis through intrinsic apoptotic pathways in established U87MG cells.
format Online
Article
Text
id pubmed-8585078
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85850782021-11-12 RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma Tsai, Tai-Hsin Lieu, Ann-Shung Huang, Tzuu-Yuan Kwan, Aij-Lie Lin, Chih-Lung Hsu, Yi-Chiang J Clin Med Article Background: Malignant glioma (MG) is an aggressive malignant brain tumor. Despite advances in multidisciplinary treatment, overall survival rates remain low. A trifluoroethyl amide derivative of 2-cyano-3-,12-dioxoolean-1,9-dien-28-oic acid (CDDO), CDDO–trifluoroethyl amide (CDDO–TFEA) is a nuclear erythroid 2-related factor 2/antioxidant response element pathway activator. RTA404 is used to inhibit proliferation and induce apoptosis in cancer cells. However, its effect on tumorigenesis in glioma is unclear. Methods: This in vitro study evaluated the effects of RTA404 on MG cells. We treated U87MG cell lines with RTA404 and performed assessments of apoptosis and cell cycle distributions. DNA content and apoptosis induction were subjected to flow cytometry analysis. The mitotic index was assessed based on MPM-2 expression. Protein expression was analyzed through Western blotting. Results: RTA404 significantly inhibited the cell viability and induced cell apoptosis on the U87MG cell line. The Annexin-FITC/PI assay revealed significant changes in the percentage of apoptotic cells. Treatment with RTA404 led to a significant reduction in the U87MG cells’ mitochondrial membrane potential. A significant rise in the percentage of caspase-3 activity was detected in the treated cells. In addition, these results suggest that cells pass the G2 checkpoint without cell cycle arrest by RTA404 treatment in the MPM-2 staining. An analysis of CHK1, CHK2, and p-CHK2 expression suggested that the DNA damage checkpoint system seems also to be activated by RTA404 treatment in established U87MG cells. Therefore, RTA404 may not only activate the DNA damage checkpoint system, it may also exert apoptosis in established U87MG cells. Conclusions: RTA404 inhibits the cell viability of gliomas and induces cancer cell apoptosis through intrinsic apoptotic pathway in Malignant glioma. In addition, the DNA damage checkpoint system seems also to be activated by RTA404. Taken together, RTA404 activated the DNA damage checkpoint system and induced apoptosis through intrinsic apoptotic pathways in established U87MG cells. MDPI 2021-10-20 /pmc/articles/PMC8585078/ /pubmed/34768325 http://dx.doi.org/10.3390/jcm10214805 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tsai, Tai-Hsin
Lieu, Ann-Shung
Huang, Tzuu-Yuan
Kwan, Aij-Lie
Lin, Chih-Lung
Hsu, Yi-Chiang
RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title_full RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title_fullStr RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title_full_unstemmed RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title_short RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma
title_sort rta404, an activator of nrf2, activates the checkpoint kinases and induces apoptosis through intrinsic apoptotic pathway in malignant glioma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585078/
https://www.ncbi.nlm.nih.gov/pubmed/34768325
http://dx.doi.org/10.3390/jcm10214805
work_keys_str_mv AT tsaitaihsin rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma
AT lieuannshung rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma
AT huangtzuuyuan rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma
AT kwanaijlie rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma
AT linchihlung rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma
AT hsuyichiang rta404anactivatorofnrf2activatesthecheckpointkinasesandinducesapoptosisthroughintrinsicapoptoticpathwayinmalignantglioma